Fundraising Fox
GyreOx Therapeutics
1 known investors
Find your way into GyreOx Therapeutics
Sign up to see every warm intro you have to GyreOx Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the GyreOx Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Gyre Therapeutics is a biopharmaceutical company developing small-molecule therapeutics for organ fibrosis and inflammatory diseases, with its lead program F351 in clinical evaluation for liver fibrosis in the US and China. The company also operates Cullgen Inc., a subsidiary focused on targeted protein degrader therapies for cancer and inflammatory conditions.
Founders & leadership
YL
Ying Luo, Ph.D.Chief Executive Officer
YX
Yue XiongChief Scientific Officer
Board
PZ
Ping ZhangChairman
Investors · 1
Frequently asked questions
- What does GyreOx Therapeutics do?
- Gyre Therapeutics is a biopharmaceutical company developing small-molecule therapeutics for organ fibrosis and inflammatory diseases, with its lead program F351 in clinical evaluation for liver fibrosis in the US and China. The company also operates Cullgen Inc., a subsidiary focused on targeted protein degrader therapies for cancer and inflammatory conditions.
- Who are GyreOx Therapeutics's investors?
- GyreOx Therapeutics's investors include Future Planet Capital.
- Where is GyreOx Therapeutics headquartered?
- GyreOx Therapeutics is headquartered in Null, US.